EVIO (EVIO) Common Stock: $0.01 Mil (As of Jun. 2020)


What is EVIO Common Stock?

EVIO EVIO -98.00% Common Stock is $0.01 Mil as of Jun. 2020.

EVIO's quarterly common stock increased from Dec. 2019 ($0.01 Mil) to Mar. 2020 ($0.01 Mil) and increased from Mar. 2020 ($0.01 Mil) to Jun. 2020 ($0.01 Mil).

EVIO's annual common stock increased from Sep. 2017 ($0.00 Mil) to Sep. 2018 ($0.00 Mil) and increased from Sep. 2018 ($0.00 Mil) to Sep. 2019 ($0.00 Mil).

EVIO Common Stock Historical Data

* Premium members only.

The historical data trend for EVIO's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVIO Common Stock Chart

EVIO Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19
Common Stock
0.04 0.00 0.00 0.00 0.00

EVIO Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.01 0.01 0.01

EVIO Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
EVIO (EVIO) has a Common Stock of $0.01 Mil as of Jun. 2020. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on EVIO and its competitors.
Is EVIO's Common Stock too high?
EVIO's current Common Stock is $0.01 Mil.
How does EVIO's Common Stock compare to VCBD and ACCA?
EVIO's Common Stock of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on EVIO and its competitors. EVIO's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVIO stock overvalued right now?
EVIO (EVIO) has a current Common Stock of $0.01 Mil. The current Common Stock is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For EVIO (EVIO), the current Common Stock is $0.01 Mil as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVIO Business Description

Address 2654 W. Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052
EVIO Inc is a Colorado corporation and a diversified holding company. Its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. The Company performs analytical testing for cannabis and cannabis-derived products, including hemp and CBD products. Its current operations also include pharmaceutical, environmental, stability, and analytical testing, as well as residential and commercial construction and investments, with operations in the United States and Canada.